BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B

Fluvastatin

An indole-heptanoic acid derivative that inhibits HMG COA REDUCTASE and is used to treat HYPERCHOLESTEROLEMIA. In contrast to other statins, it does not appear to interact with other drugs that inhibit CYP3A4.

297+ PubMed studies analyzed · 53 RCTs · Evidence Score: 49.9

Research Domains

Fluvastatin has been studied across 19 research domains including ❤️ Cardiovascular, 😴 Sleep, 🔥 Metabolic, 🔬 Oncology, 🫁 Liver & Detox. The primary research focus is ❤️ Cardiovascular with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Fluvastatin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Canagliflozin
4 shared targets
beta
4 shared targets
Cerulenin
4 shared targets
Teniposide
4 shared targets
casin
4 shared targets
Galactitol
2 shared targets
Carbutamide
2 shared targets
Pyrrolidonecarboxylic
2 shared targets
KN
4 shared targets
Carduus
2 shared targets
Loading evidence profile...

This evidence profile for Fluvastatin is generated deterministically from 297 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.